{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Texas Responds to DEA Announcement Allowing Prescription of Controlled Substances via Telemedicine during COVID-19 Emergency",
"url": "https://www.lexblog.com/2020/03/20/texas-responds-to-dea-announcement-allowing-prescription-of-controlled-substances-via-telemedicine-during-covid-19-emergency/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-P46DA8BN",
"url": "https://www.lexblog.com/lib/P46DA8BN/"
},
"datePublished": "2020-03-20T17:57:57-04:00",
"dateModified": "2024-05-17T09:58:33-04:00",
"author": {
"@type": "Person",
"name": "Julian Rivera, Theresa Langley"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Husch Blackwell LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Healthcare Law Insights",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.healthcarelawinsights.com/?p=4363",
"sourceStability": "may-move"
}